Messages in brief

An overview of information by BASG to the novel Corona virus SARS-CoV-2 and the COVID-19 disease as well as links to websites with further information.

National Vaccination Committee recommends extended dosage intervals for mRNA vaccines

The Austrian Federal Office for Safety in Health Care (BASG) informs that the temporarily put on hold batch ABV 5300 of AstraZeneca's COVID 19 vaccine has been released again and can be vaccinated.

Currently, there is no evidence of a causal relationship with vaccination.

In cooperation with the pharmaceutical industry, the BASG has produced a guideline for processing DHPC (Direct Healthcare Professional Communication) and Educational Material.

On 29. January 2021, "COVID-19 Vaccine AstraZeneca" was authorised in the European Union as the third vaccine against SARS-CoV2.

To simplify the reporting of suspected adverse reactions of medicines and vaccines a revised online form is now available for patients.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

The United Kingdom has left the European Union and the transition period ended on 31 December 2020. This article gives a short overview about the current applicable rules.

On 06. January 2021, "COVID-19 Vaccine Moderna" was authorised in the European Union as the second vaccine against SARS-CoV2.